Merck Serono breaks ground on $72M R&D center

Merck Serono is investing $72 million in a new R&D complex in Darmstadt, Germany. The biotech arm of Merck KGaA is building a 16,000-square-meter addition to accommodate 200 research staffers, noting that the facility should be ready in 2017. Merck Serono underwent a major reorganization several years ago, concentrating R&D in Germany and in Massachusetts after shuttering a campus in Switzerland. Story

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.